DRS B4

General Information


DRACP ID  DRACP01094

Peptide Name   DRS B4

Sequence  ALWKDILKNVGKAAGKAVLNTVTDMVNQ

Sequence Length  28

UniProt ID  P81486  C0HLC4 

PubChem CID  Not available

Origin  Dermaseptins B

Type  Native peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
MCF-7 Invasive breast carcinoma of no special type Carcinoma Cytotoxicity=15 µM Thymidine Incorporation assay 6 h 1

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antimicrobial



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01094

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C133H225N37O39S

Absent amino acids  CEFHPRSY

Common amino acids  AKV

Mass  348035

Pl  10.33

Basic residues  4

Acidic residues  2

Hydrophobic residues  13

Net charge  2

Boman Index  -2060

Hydrophobicity  7.5

Aliphatic Index  111.43

Half Life 
  Mammalian: 1.3 hour
  Yeast: 3 min
  E.coli: 2 min

Extinction Coefficient cystines  5500

Absorbance 280nm  203.7

Polar residues  7

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 9614066

Title  Structure, synthesis, and molecular cloning of dermaseptins B, a family of skin peptide antibiotics

Doi 10.1074/jbc.273.24.14690

Year  1998

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.